An Updated Natural History Model of Cervical Cancer: Derivation of Model Parameters

Impact of Vaccination on 14 High-Risk HPV Type Infections: A Mathematical Modelling Approach

(2013) Simopekka Vänskä et al.   PLoS One

A population-based study of human papillomavirus genotype prevalence in the United States: Baseline measures prior to mass human papillomavirus vaccination

(2012) Cosette M. Wheeler et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16

(2012) Jacolien van der Marel et al.   INTERNATIONAL JOURNAL OF CANCER

Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis

(2012) Nicolas Van de Velde et al.   JNCI-Journal of the National Cancer Institute

The Need for Forward-Looking Decision Analyses to Guide Cervical Cancer Prevention

(2011) M. Schiffman   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Incident Cervical HPV Infections in Young Women: Transition Probabilities for CIN and Infection Clearance

(2011) R. P. Insinga et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Human Papillomavirus (HPV) 6, 11, 16, and 18 Prevalence Among Females in the United States—National Health and Nutrition Examination Survey, 2003–2006: Opportunity to Measure HPV Vaccine Impact?

(2011) Eileen F. Dunne et al.   JOURNAL OF INFECTIOUS DISEASES

Prevalence of Genital Human Papillomavirus Among Females in the United States, the National Health and Nutrition Examination Survey, 2003–2006

(2011) Susan Hariri et al.   JOURNAL OF INFECTIOUS DISEASES

Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection

(2010) A. C. Rodriguez et al.   JNCI-Journal of the National Cancer Institute

Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence

(2010) S. K. Kjaer et al.   JNCI-Journal of the National Cancer Institute

Benefits and risks of HPV testing in cervical cancer screening

(2010) Philip E Castle et al.   LANCET ONCOLOGY

Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model

(2009) Ralph P Insinga et al.   BMC INFECTIOUS DISEASES

Bayesian Calibration of Microsimulation Models

(2009) Carolyn M. Rutter et al.   JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION

Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States

(2009) Cosette M. Wheeler et al.   JNCI-Journal of the National Cancer Institute

Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines

(2009) Natasha K. Stout et al.   PHARMACOECONOMICS

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

(2008) Margaret RE McCredie et al.   LANCET ONCOLOGY

Health and Economic Implications of HPV Vaccination in the United States

(2008) Jane J. Kim et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica

(2008) Rolando Herrero et al.   VACCINE